NASDAQ:DRADDigirad Stock Price, Forecast & News

Digirad's stock was trading at $3.46 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, DRAD shares have decreased by 29.2% and is now trading at $2.45. View which stocks have been most impacted by Coronavirus.

Digirad is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Digirad.

Digirad Co. (NASDAQ:DRAD) released its quarterly earnings data on Friday, May, 15th. The medical equipment provider reported ($0.81) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($1.05) by $0.24. The medical equipment provider earned $28.86 million during the quarter. Digirad had a positive return on equity of 0.59% and a negative net margin of 4.97%. View Digirad's earnings history.

Digirad shares reverse split on the morning of Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 4th 2019. An investor that had 100 shares of Digirad stock prior to the reverse split would have 10 shares after the split.

Digirad issued an update on its FY 2020 Pre-Market earnings guidance on Friday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $125-145 million.

News headlines about DRAD stock have trended somewhat negative recently, according to InfoTrie. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Digirad earned a news sentiment score of -1.6 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutDigirad.

Digirad saw a increase in short interest in May. As of May 15th, there was short interest totaling 76,000 shares, an increase of 97.9% from the April 30th total of 38,400 shares. Based on an average daily volume of 267,400 shares, the days-to-cover ratio is presently 0.3 days. Currently, 4.1% of the shares of the company are sold short. View Digirad's Current Options Chain.

Some companies that are related to Digirad include Second Sight Medical Products (EYES), CHF Solutions (CHFS), ENDRA Life Sciences (NDRA), Viveve Medical (VIVE), Vaso (VASO), ReShape Lifesciences (RSLSD), Guided Therapeutics (GTHP), Nexeon Medsystems (NXNN), Echo Therapeutics (ECTE), 21st North (ULGX), Escalon Medical (ESMC), IMRIS (IMRSQ), Magna-Lab (MAGAA), Newcardio (NWCI) and Non-Invasive Monitoring Systems (NIMU). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Digirad investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), AbbVie (ABBV), Exelixis (EXEL), Cronos Group (CRON), General Electric (GE), Novavax (NVAX), Pfizer (PFE) and Rigel Pharmaceuticals (RIGL).

Digirad trades on the NASDAQ under the ticker symbol "DRAD."

Shares of DRAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DRAD stock can currently be purchased for approximately $2.45.

Digirad has a market capitalization of $5.14 million and generates $114.18 million in revenue each year. Digirad employs 452 workers across the globe.

The official website for Digirad is www.digirad.com.

Digirad's mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 30024. The medical equipment provider can be reached via phone at 858-726-1600 or via email at ir.digirad.com.